Greenfield Medicinal Cannabis is a licensed medicinal cannabis importer and distributor in Australia.

A team of established industry leaders

 
GREENFIELD_HEADER4.jpg

Our Team

Greenfield MC is its people. It takes the best people to deliver the best product.

GREENFIELD_NH_01.jpg

Nicholas Hanna 
Chief Executive Officer
 

Nicholas is a lawyer who specialises in health, drug and regulatory law, with significant experience in the Australian medicinal cannabis space. He has advised medicinal cannabis businesses and has a wealth of knowledge about regulatory and legal frameworks governing the industry. Nicholas founded and ran a successful law firm in Sydney for almost a decade and has substantial experience dealing with the Medical Council of NSW, Health Care Complaints Commission, and various other government departments and regulatory bodies. He has personal interests in medicinal cannabis assets in Canada, Colombia, Germany and the USA.

GREENFIELD_SA_01.jpg

A/Prof, Dr Sree Appu,
Chief Medical Officer,
Chairman of the Medical Board

Sree is a leading Uro-Oncologist and the recent Clinical Head of Urology for the Monash Cancer Centre. He is the Head of Southern Urology as well as IMAGENEX, a medical cancer screening service. Sree is also an academic researcher and was appointed Associate Professor in Urology by Monash University in 2012. He has published more than 50 peer reviewed articles in various medical journals and has served as an examiner, international reviewer and educator.

GREENFIELD_AC_01.jpg

Arjun Chhabra
Chairman and President
 

Arjun is a lawyer who specialises in corporate, drug, health and regulatory law. He has a background in mergers and acquisitions, capital raisings and corporate governance. Arjun has worked with start-ups and in emerging markets, having worked as a corporate lawyer in Australia, the Asia-Pacific and the Middle East, and as an investment banker in sub-Saharan Africa. He has worked with Deloitte, Blake Dawson (now Ashurst), Baker & McKenzie, Clyde & Co, and was the Chief Executive Officer of Anthesis Capital.

Greenfield_katy.jpg

Katy Williams Day
Chief Operating Officer

Katy is a pharmacist with over 20 years of commercial experience in the medical and pharmacological industries. She has held senior leadership positions at global pharmaceutical and listed medicinal cannabis companies including Merck Serono, Phebra, Sandoz, Pfizer and Genzyme Australasia (a Sanofi company). Katy specialises in the launch and commercialisation of new drugs and products, as well as overseeing clinical research trials.

GREENFIELD_SM_01.jpg

Sandip Manku
Pharmaceutical and
Risk Compliance Officer  

Sandip is a registered Australian Pharmacist and a Member of the Society of Hospitals Pharmacists Australia. He has worked in the pharmaceutical industry for over 20 years in various sales and management roles in Roche Australia, Pfizer Australia, Sandoz Australia and Hospira Australia. Sandip specialises in hospital pharmaceuticals and orphan drugs.

Greenfield_janja.jpg

Janja Diana Jelic
Patient and Doctor Relations

Janja is a registered pharmacist and member of the Australian Association of Consultant Pharmacy. She provides personalised Medication Management Reviews for people living in the community and aged care facilities, working closely with their GPs to optimise medication use and health outcomes. Janja has extensive experience in the medicinal cannabis industry around issues concerning doctor and patient access.

GREENFIELD_ID_01.jpg

Ivon Diaz 
Quality Control Officer 

Ivon has worked in global pharmaceutical and health companies for 14 years in Colombia, Australia and the United Kingdom. Most recently she has worked in the UK with Reckitt Benckiser as the Health Hub Quality Commercial Manager, and in their Australian subsidiary as the New Product Implementation Manager Australia and New Zealand, as well as Senior Quality Compliance Coordinator Australia and New Zealand. In Colombia, Ivon worked with Biochem Farmaceutica de Colombia as a New Product Development and Regulatory Affairs Associate, and prior to that with Schering AG (now Bayer AG) as a Quality Control and Quality Assurance Associate.

GREENFIELD_MH_01.jpg

Meilani Humphreys
Sales and
Distribution Officer 

Meilani has worked in global pharmaceutical companies for over 15 years. She has worked at Roche Australia, Pfizer Australia and Nutricia Australia. Meilani has held several sales and distribution roles and worked in new business development. Her previous positions have included Pharmaceutical Sales Officer, Hospital and Medical Clinic Specialist, Medical Devices Territory Manager and Senior Relationship Officer. Meilani brings a wealth of experience in launching new pharmaceutical products.

GREENFIELD_AG_01.png

Anthony George
Financial Officer
 

Anthony is a Chartered Accountant and Registered Tax Agent with nearly 20 years experience working in the Finance team at Pfizer Australia. At Pfizer Australia he held the following positions: Head of Finance Operations Australia and New Zealand; Company Secretary; Finance Manager; Financial Services Manager, Financial Controller and Chief Accountant. Anthony has significant experience in corporate governance, business development and mergers and acquisitions. Prior to joining Pfizer Australia, Anthony worked at Touche Tohmatsu (now Deloitte).

 
GREENFIELD_SA_01.jpg

A/Prof, Dr Sree Appu,
Chief Medical Officer,
Chairman of the Medical Board

Sree is a leading Uro-Oncologist and the recent Clinical Head of Urology for the Monash Cancer Centre. He is the Head of Southern Urology as well as IMAGENEX, a medical cancer screening service. Sree is also an academic researcher and was appointed Associate Professor in Urology by Monash University in 2012. He has published more than 50 peer reviewed articles in various medical journals and has served as an examiner, international reviewer and educator.

Iansek.png

Prof. Robert Iansek 
Neurologist 
OAM
B Med Sci, MBBS, PhD, FRACP

Robert is a Professor of Geriatric Neurology at Monash University, as well as the Director of the Clinical Research Centre for Movement Disorders & Gait and Director of the Victorian Comprehensive Parkinson’s Program at the Kingston Centre, Southern Health. In 2013, Robert was awarded the Medal of the Order of Australia, the country’s highest honour, for services to medicine in the field of Neurology. He has published over 200 articles in peer-reviewed journals and edited three books.

Singh.png

Associate Prof. Ajeet Singh
Psychiatrist 
MB.BS(Melo) M.Psych., FRANZCP, MD 

Ajeet is a psychiatrist and pharmacogeneticist. He is an Adjunct Associate Professor at Deakin Medical School and has worked at various leading hospitals and clinics in Australia. Ajeet is the founder of CNSdose, a US and Australian genetic testing company that analyses patients’ brains to provide medication guidance for geriatrics, primary care, neurology, internal medicine and psychiatry.

Baressi.png

Dr Ben Barresi
MBBS, FRACGP

Ben is a GP who specialises in sports medicine and addiction medicine. He was the team doctor for the Carlton Football Club and is now the Victorian match day doctor for the GWS Giants. He has been involved in AFL studies into player injuries. Ben provides GP liaison support for admitting treating psychiatrists at the substance disorders program at The Melbourne Clinic.

Karalapillai.png

Dr Dharshi Karalapillai
MBBS, FCICM, FANZCA, DDU, PhD Candidate

Dharshi is an ICU Specialist and Anaesthetist who has worked at various leading hospitals across Australia. Dharshi is due to complete a PhD this year in the field of perioperative respiratory care, and has been involved in a large randomised controlled trial of 1,240 patients. He has authored numerous research papers and articles in peer-reviewed journals and publications.

 
GREENFIELD_JL_01.jpg

John Latham 

John is a leading figure in the global pharmaceutical industry. He was the Managing Director and Chairman of Pfizer Australia from 2007 to 2012. Prior to that he was the Country Manager of Pfizer Singapore and Country Manager of Pfizer Malaysia. He was previously at Bristol-Myers Squibb as the Regional Finance Director Asia, Middle East & Africa, variously located between Princeton, New Jersey and Brussels. Before entering the pharmaceutical industry, he worked at PricewaterhouseCoopers in their Jakarta, Toronto and Sydney offices.

GREENFIELD_AP_01.jpg

Dr Adam Pirie

Adam is the Director of Operations at Beacon Medical Australia, a wholly-owned Subsidiary of VIVO Cannabis Inc, a publicly traded medicinal cannabis company listed on the Toronto Stock Exchange. He completed his PhD at the University of Tasmania building and managing a pre-clinical bio-prospecting program which discovered novel plant-derived compounds and therapies to treat type II diabetes, cardiovascular disease, metabolic syndrome and vascular dysfunction. Adam has experience spanning the commercial, scientific and project management activities needed for successful commercialisation of early stage biotechnology.

GREENFIELD_MA_01.jpg

Moz Ali 

Moz is a senior investment banker with over 20 years of financial services industry experience including advisory roles in Australia, UK, Europe, Asia and South Africa. His transaction experience spans mergers and acquisitions, equity and debt issuances, capital management, structuring and acquisition financing. Moz has worked with Deutsche Bank, Citi and Tillinghast. Moz’s experience in the healthcare sector includes leading a debt capital raising for Primary Health Care and more recently as part of the team advising the Australian Federal Government on the $5.7B privatisation and IPO of Medibank Private.

GREENFIELD_TH_01.jpg

Tristan Hyodo  

Tristan is the Chief Executive Officer of MC Therapeutics Pty Ltd, a Queensland-based medicinal cannabis cultivator.  He has a background in the health supplements, nutraceuticals, and wellbeing markets. Tristan has held research, quality control, and product development roles in the FMCG industry, and worked for several years at Australia’s largest health food company.